De Novo Design
Evaluation of model-designed nanobodies
Candidate statistics
| Protein name | Target | Subset | Design workflow | SEC purity (%) | SDS purity (%) | Single-point BLI net response | Nonspecific binding signal BVP ELISA measures nonspecific antibody binding to baculovirus particles. The reported value is a background-corrected net signal. Under matching assay and normalization conditions, lower values generally indicate less nonspecific binding. The assay helps assess polyreactivity and the risk of rapid clearance in vivo.Assay reference |
|---|---|---|---|---|---|---|---|
| RFantibody-IL7RA-041 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | Low concentration; abnormal peak | 0.0006 | ||
| RFantibody-IL7RA-042 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | Low concentration; abnormal peak | -0.0029 | ||
| RFantibody-IL7RA-043 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | 51.4 | 0.0015 | ||
| RFantibody-IL7RA-044 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | Low concentration; abnormal peak | 0.0017 | ||
| RFantibody-IL7RA-045 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | 98.6 | 98.8 | -0.0083 | |
| RFantibody-IL7RA-046 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | Low concentration; abnormal peak | -0.0007 | ||
| RFantibody-IL7RA-047 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | Low concentration; abnormal peak | 0.0041 | ||
| RFantibody-IL7RA-048 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | Low concentration; abnormal peak | 0.0047 | ||
| RFantibody-IL7RA-049 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | Low concentration; abnormal peak | 0.001 | ||
| RFantibody-IL7RA-050 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | 98.9 | 96.8 | -0.0078 | |
| RFantibody-IL7RA-051 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | Low concentration; abnormal peak | 0.001 | ||
| RFantibody-IL7RA-052 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | Purification failed | |||
| RFantibody-IL7RA-053 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | 0.0085 | |||
| RFantibody-IL7RA-054 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | Aggregation | 0.0001 | ||
| RFantibody-IL7RA-055 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | Aggregation | 0.0046 | ||
| RFantibody-IL7RA-056 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | 97 | 99.3 | -0.0011 | |
| RFantibody-IL7RA-057 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | 0.0008 | |||
| RFantibody-IL7RA-058 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | Low concentration; abnormal peak | 0.0056 | ||
| RFantibody-IL7RA-059 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | 80.2 | 97.7 | 0.0029 | |
| RFantibody-IL7RA-060 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | Aggregation | -0.0014 |
20 candidates